Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis
Clinical trial NCT06747858 · RECRUITING
Trial details
- NCT number
- NCT06747858
- Sponsor
- Arcturus Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2027-06-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.